Mirum Pharmaceuticals, Inc. MIRM Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s compensation and benefits?
- Mirum Pharmaceuticals, Inc. (MIRM) reported compensation and benefits of $35.43M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s compensation and benefits changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s compensation and benefits increased by 113.5% year-over-year, from $16.6M to $35.43M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s compensation and benefits?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s compensation and benefits has grown at a 50.3% compound annual growth rate (CAGR), from $20.94M to $47.28M.